Lexeo Therapeutics, Inc.·4

Feb 21, 5:09 PM ET

Adler Eric 4

4 · Lexeo Therapeutics, Inc. · Filed Feb 21, 2025

Insider Transaction Report

Form 4
Period: 2025-02-19
Adler Eric
Chief Medical Officer
Transactions
  • Sale

    Common Stock

    2025-02-19$4.41/sh2,359$10,41068,266 total
Footnotes (2)
  • [F1]Represents a sale to cover tax obligations on the release of restricted stock units ("RSUs").
  • [F2]Includes 63,906 RSUs.

Documents

1 file
  • 4
    form4-02212025_100209.xmlPrimary